• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期调节因子cdk2ap1抑制前列腺癌细胞生长并改变雄激素反应途径功能。

Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.

作者信息

Zolochevska Olga, Figueiredo Marxa L

机构信息

Department of Comparative Biomedical Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge, Louisiana 70803, USA.

出版信息

Prostate. 2009 Oct 1;69(14):1586-97. doi: 10.1002/pros.21007.

DOI:10.1002/pros.21007
PMID:19585490
Abstract

BACKGROUND

We evaluated the effect of expressing the cell cycle regulator cdk2ap1, downregulated in prostate cancer cell lines, in inhibiting prostate cancer cell growth.

METHODS

Expression of cdk2ap1 using a tet-inducible lentiviral system modified growth rate, induced cell cycle arrest and apoptosis and reduced the invasive ability of prostate cancer cell lines, as assayed by cell viability, cell cycle profiling, Caspase 3/7 detection, and matrigel invasion assays. We examined the effect of expressing cdk2ap1 on gene expression profiles of cytokine, invasion, apoptotic, and androgen response pathways using quantitative real-time PCR, and used androgen-responsive reporter gene assays, and methylation-sensitive PCR to examine the mechanism of cdk2ap1 interaction with androgen-responsive pathways.

RESULTS

The expression of cdk2ap1 correlated with a reduction in cellular growth, irrespective of inhibition or stimulation of androgen receptor (AR) signaling pathways. Cell cycle arrest, increased apoptosis, and a reduction in invasiveness phenotypes were observed upon cdk2ap1 expression. Enhanced demethylation at the AR promoter, AR expression increases, and enhanced AR transcriptional activity correlated with cdk2ap1 expression.

CONCLUSIONS

Our findings support a novel concept by which cell cycle inhibitor genes can impact prostate cancer phenotypes by restoring a tumor suppressive function to androgen-responsive pathways and this function may involve modulation of a subset of functions of the AR.

摘要

背景

我们评估了在前列腺癌细胞系中表达下调的细胞周期调节因子cdk2ap1对抑制前列腺癌细胞生长的作用。

方法

使用四环素诱导的慢病毒系统表达cdk2ap1,通过细胞活力、细胞周期分析、半胱天冬酶3/7检测和基质胶侵袭试验检测其对前列腺癌细胞系生长速率、诱导细胞周期停滞和凋亡以及降低侵袭能力的影响。我们使用定量实时PCR检测表达cdk2ap1对细胞因子、侵袭、凋亡和雄激素反应途径基因表达谱的影响,并使用雄激素反应性报告基因试验和甲基化敏感性PCR检测cdk2ap1与雄激素反应途径相互作用的机制。

结果

无论雄激素受体(AR)信号通路受到抑制还是刺激,cdk2ap1的表达都与细胞生长的减少相关。cdk2ap1表达后观察到细胞周期停滞、凋亡增加和侵袭性表型减少。AR启动子处的去甲基化增强、AR表达增加以及AR转录活性增强与cdk2ap1表达相关。

结论

我们的研究结果支持了一个新的概念,即细胞周期抑制基因可以通过恢复雄激素反应途径的肿瘤抑制功能来影响前列腺癌表型,并且这种功能可能涉及对AR一部分功能的调节。

相似文献

1
Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.细胞周期调节因子cdk2ap1抑制前列腺癌细胞生长并改变雄激素反应途径功能。
Prostate. 2009 Oct 1;69(14):1586-97. doi: 10.1002/pros.21007.
2
PC3, but not DU145, human prostate cancer cells retain the coregulators required for tumor suppressor ability of androgen receptor.PC3人前列腺癌细胞保留了雄激素受体发挥肿瘤抑制能力所需的共调节因子,而DU145人前列腺癌细胞则不然。
Prostate. 2006 Sep 1;66(12):1329-38. doi: 10.1002/pros.20483.
3
TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.转化生长因子-β信号传导和雄激素受体状态决定了人类前列腺癌细胞中的凋亡串扰。
Prostate. 2008 Feb 15;68(3):287-95. doi: 10.1002/pros.20698.
4
Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.雄激素受体依赖性Bcl-xL表达调控:对前列腺癌进展的影响。
Prostate. 2008 Mar 1;68(4):453-61. doi: 10.1002/pros.20723.
5
GCP-mediated growth inhibition and apoptosis of prostate cancer cells via androgen receptor-dependent and -independent mechanisms.GCP通过雄激素受体依赖性和非依赖性机制介导前列腺癌细胞的生长抑制和凋亡。
Prostate. 2007 Apr 1;67(5):521-35. doi: 10.1002/pros.20548.
6
The androgen receptor and prostate cancer invasion.雄激素受体与前列腺癌侵袭
Mol Cell Endocrinol. 2006 Feb 26;246(1-2):157-62. doi: 10.1016/j.mce.2005.11.006. Epub 2005 Dec 20.
7
HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.HOXC8 通过抑制 SRC-3 募集到直接雄激素靶基因,从而抑制人前列腺癌细胞中的雄激素受体信号。
Mol Cancer Res. 2010 Dec;8(12):1643-55. doi: 10.1158/1541-7786.MCR-10-0111. Epub 2010 Nov 2.
8
ACTR/AIB1/SRC-3 and androgen receptor control prostate cancer cell proliferation and tumor growth through direct control of cell cycle genes.ACTR/AIB1/SRC-3与雄激素受体通过直接调控细胞周期基因来控制前列腺癌细胞增殖和肿瘤生长。
Prostate. 2006 Oct 1;66(14):1474-86. doi: 10.1002/pros.20477.
9
Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.叉头转录因子FOXP1的表达与前列腺癌中的缺氧诱导因子(HIFs)和雄激素受体均相关,但不受雄激素或缺氧的直接调控。
Prostate. 2007 Jul 1;67(10):1091-8. doi: 10.1002/pros.20583.
10
Expression of a hyperactive androgen receptor leads to androgen-independent growth of prostate cancer cells.雄激素受体过度激活会导致前列腺癌细胞的雄激素非依赖性生长。
J Mol Endocrinol. 2008 Jul;41(1):13-23. doi: 10.1677/JME-07-0158. Epub 2008 May 9.

引用本文的文献

1
Consistent DNA Hypomethylations in Prostate Cancer.前列腺癌中的一致性 DNA 低甲基化。
Int J Mol Sci. 2022 Dec 26;24(1):386. doi: 10.3390/ijms24010386.
2
Analyzing the Effects of Intrauterine Hypoxia on Gene Expression in Oocytes of Rat Offspring by Single Cell Transcriptome Sequencing.通过单细胞转录组测序分析宫内缺氧对大鼠子代卵母细胞基因表达的影响
Front Genet. 2019 Nov 12;10:1102. doi: 10.3389/fgene.2019.01102. eCollection 2019.
3
mRNA Expression of in Human Breast Cancer: Correlation with Clinical and Pathological Parameters.
人乳腺癌中[具体内容缺失]的mRNA表达:与临床和病理参数的相关性
Cancer Genomics Proteomics. 2018 Nov-Dec;15(6):447-452. doi: 10.21873/cgp.20103.
4
Knockdown of CDK2AP1 in primary human fibroblasts induces p53 dependent senescence.在原代人成纤维细胞中敲低CDK2AP1会诱导p53依赖性衰老。
PLoS One. 2015 Mar 18;10(3):e0120782. doi: 10.1371/journal.pone.0120782. eCollection 2015.
5
CDK2-AP1 inhibits growth of breast cancer cells by regulating cell cycle and increasing docetaxel sensitivity in vivo and in vitro.CDK2-AP1 通过调控细胞周期和增加体内外多西紫杉醇敏感性抑制乳腺癌细胞生长。
Cancer Cell Int. 2014 Nov 30;14(1):130. doi: 10.1186/s12935-014-0130-8. eCollection 2014.
6
Human adipose-derived mesenchymal stromal cell pigment epithelium-derived factor cytotherapy modifies genetic and epigenetic profiles of prostate cancer cells.人脂肪间充质基质细胞色素上皮衍生因子细胞治疗改变前列腺癌细胞的遗传和表观遗传特征。
Cytotherapy. 2014 Mar;16(3):346-56. doi: 10.1016/j.jcyt.2013.11.012. Epub 2014 Jan 11.
7
p12(CDK2-AP1) inhibits breast cancer cell proliferation and in vivo tumor growth.p12(CDK2-AP1)抑制乳腺癌细胞增殖和体内肿瘤生长。
J Cancer Res Clin Oncol. 2012 Dec;138(12):2085-93. doi: 10.1007/s00432-012-1286-z. Epub 2012 Jul 25.
8
Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.双刃剑:CDK2AP1 在细胞周期调控和表观遗传调控中的作用。
J Dent Res. 2012 Mar;91(3):235-41. doi: 10.1177/0022034511420723. Epub 2011 Aug 24.
9
Dose-dependent differential effects of risedronate on gene expression in osteoblasts.依替膦酸二钠对成骨细胞基因表达的剂量依赖性差异作用。
Biochem Pharmacol. 2011 Apr 15;81(8):1036-42. doi: 10.1016/j.bcp.2011.01.025. Epub 2011 Feb 15.
10
Novel tumor growth inhibition mechanism by cell cycle regulator cdk2ap1 involves antiangiogenesis modulation.细胞周期调控因子 CDK2AP1 通过抑制肿瘤新血管生成的新机制。
Microvasc Res. 2010 Dec;80(3):324-31. doi: 10.1016/j.mvr.2010.06.001. Epub 2010 Jun 10.